4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Bolt Biotherapeutics, Inc. (BOLT) operates in the Biotechnology industry and is headquartered in Redwood City, United States with about 23 employees. Its market capitalization is roughly $8 million. In the fiscal year ended 2025-12-31, BOLT reported $8M in revenue and ($33M) in net income.
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies for the treatment of cancer.
Interactive charts & full statements → Open the BOLT valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $8M | $8M | $8M | $6M | — |
| Operating Income (EBIT) | ($35M) | ($68M) | ($76M) | ($90M) | — |
| Net Income | ($33M) | ($63M) | ($69M) | ($88M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $2M | $2M | $2M | $1M | — |
| Operating Income (EBIT) | ($8M) | ($6M) | ($8M) | ($9M) | ($12M) | — |
| Net Income | ($7M) | ($7M) | ($7M) | ($9M) | ($11M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $57M | $100M | $160M | $228M | — |
| Total Liabilities | $30M | $42M | $47M | $56M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BOLT viewer.
About TickerBase · Data methodology & sources